Disease Management Clinical Decisions: Immunization in Immunocompromised Patients

Disease Management Clinical Decisions: Immunization in Immunocompromised Patients is organized by Cleveland Clinic Center for Continuing Education.

Release Date: February 06, 2019
Expiration Date: February 06, 2022

Target Audience:
Directed to primary care physicians including family practitioners and internists.

Accreditation:
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Description:
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.

Learning Objectives:
After completing this case the reader should be able to:
• Critically appraise the data on the efficacy and safety of vaccinating patients with an immunocompromised condition.
• Describe the effect of immunosuppressive medications on vaccine efficacy.
• Differentiate between the various types of vaccines and incorporate the recommended vaccinations for patients receiving immunosuppressive medications into clinical practice.
• Describe the biology, risks, and benefits of the recombinant herpes zoster vaccine.

Additional details will be provided as soon as information is available.